Literature DB >> 10321935

Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.

H Buckler1, W Fraser, D Hosking, W Ryan, M J Maricic, F Singer, M Davie, I Fogelman, C A Birbara, A M Moses, K Lyles, P Selby, P Richardson, J Seaman, K Zelenakas, E Siris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10321935     DOI： 10.1016/s8756-3282(99)00071-x

Source DB:  PubMed          Journal:  Bone        ISSN： 1873-2763            Impact factor:   4.398


× No keyword cloud information.
  10 in total

1.  Active Paget's disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature.

Authors:  Lamprini Gkouva; Maria Andrikoula; Vasilis Kontogeorgakos; Dionysios J Papachristou; Agathocles Tsatsoulis
Journal:  Clin Rheumatol       Date:  2010-10-01       Impact factor: 2.980

Review 2.  Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.

Authors:  Gillian M Keating; Lesley J Scott
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Intravenous bisphosphonate therapy for osteoporosis: where do we stand?

Authors:  Henry G Bone; Werner Schurr
Journal:  Curr Osteoporos Rep       Date:  2004-03       Impact factor: 5.096

Review 4.  The use of zoledronic acid for Paget's disease of bone.

Authors:  Michael Maricic
Journal:  Curr Osteoporos Rep       Date:  2006-03       Impact factor: 5.096

Review 5.  Bisphosphonates for Paget's disease of bone in adults.

Authors:  Luis Corral-Gudino; Adrian Jh Tan; Javier Del Pino-Montes; Stuart H Ralston
Journal:  Cochrane Database Syst Rev       Date:  2017-12-01

Review 6.  Role of zoledronic acid in the prevention and treatment of osteoporosis.

Authors:  Agnès Räkel; Andrée Boucher; Louis-Georges Ste-Marie
Journal:  Clin Interv Aging       Date:  2011-03-28       Impact factor: 4.458

7.  Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?

Authors:  Anne L Langston; Marie Johnston; Clare Robertson; Marion K Campbell; Vikki A Entwistle; Theresa M Marteau; Marilyn McCallum; Stuart H Ralston
Journal:  BMC Health Serv Res       Date:  2006-06-08       Impact factor: 2.655

8.  Use of zoledronic acid in the treatment of Paget's disease.

Authors:  Margaret Seton; Stephen M Krane
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

9.  Varus deformity of the left lower extremity causing degenerative lesion of the posterior horn of the left medial meniscus in a patient with Paget's disease of bone.

Authors:  Ali Al Kaissi; Rudolf Ganger; Gabriel Mindler; Klaus Klaushofer; Franz Grill
Journal:  Ger Med Sci       Date:  2014-09-25

Review 10.  Current options for the treatment of Paget's disease of the bone.

Authors:  Daniela Merlotti; Luigi Gennari; Giuseppe Martini; Ranuccio Nuti
Journal:  Open Access Rheumatol       Date:  2009-07-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.